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Chapter 1: Background
1.1 Introduction
The chemistry of transition metal phosphonates has enormous potential
and diverse applications such as gas separation, gas storage or catalyst systems
which have been explored in detail.1-6 In contrast, analogous chemistry with the sblock elements has received only a little attention. Calcium was the priority
element in our study due to its bioactive properties. Previous studies proved that
phosphonates can possibly be used as bone repair materials.1 The possible
applications are only possible with structures with pores or channels for other
molecules to enter. Thus, the control of the shape and size of pores or channels
are significant for its applications.7
The use of phosphonates and diphosphonates are widely used because they
have shown significant therapeutic features for bone related diseases.8,9 While
exogenous phosphonic acids are known to bind to calcium in the bone,
diphosphonates are known as agents for suppressing resorption of bone.10,11 Thus,
commonly used diphosphonic acid based drugs are Zoledronate, Alendronate,
Ibandronate, and Etidronate and is shown in Table 1.12 These drugs are used in
clinics to treat bone disorders such as osteoporosis, bone metastases,
hypercalcemia and Paget’s disease. They also cause significant increase in bone
mass and decrease in fracture rates by 50%.13

2

Table 1. List of known drugs for treating bone diseases.
Compound Name Structure
Zoledrinic acid

Brand Name(s)
N
Reclast
Zometa
Zomera
Aclasta

Alendronic acid

Fosamax

Ibandronic acid

Bonvia
Bondronate
Bonviva

Etidronic acid

Didronel

The use of diphosphonic acid based drugs is possibly due to their
similarity to hydroxyapatite
hydroxyapatite, an important substance in skeletal system,
system and their
resistance to chemical breakdown or hydr
hydrolysis.14
Furthermore, the potential use of phosphonates
ates and diphosphonates as
biomimetric substances is extended by the successful use of mono and
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diphosphonates to destroy a variety of protozoa and parasites which are
responsible for diseases such as malaria and sleeping sickness (African
trypanosomiasis).15,16 Another significant use of diphosphonates is in water
softener (Calgon) to prevent scaling.17
1.2 Aims and objectives
This project is geared to gain synthetic access to magnesium and calcium
phosphonates, to develop synthetic methodologies, and obtain an understanding
of structure determining factors in the process of MOFs. The project consists of
the preparation of ligand, 3-oxapentane-1,5-diphosphonic acid and metal
complexes with the ligand. In addition, it consists of optimization of crystal
growth conditions, and structural analysis by single crystal X-ray diffraction.
1.3 Literature review
1.3.1 Bone material
The skeletal system is the body system that consists of bone, cartilage,
tendons, and ligaments. The known functions of the skeletal system are support,
protection, movement, blood production, and bone marrow storage.18,19 The rigid
characteristic of the bones allows them to be the most suitable for supporting
tissue of the body and providing support. Bones are often found in different
cavities in our body system protecting organs such as the brain. The detailed
structure of bones is shown in Figure 1. 20
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Figure 1. Human Bone Structure

Many bones contain cavities, also called lacuna, filled with marrow. Bone
marrow has two different types: red and yellow. Red marrow is the site of blood
production while yellow marrow stores adipose tissue. It is only the red marrow
which produces red and white blood cells. When the red marrow is surrounded by
a framework of reticular fibers it is called hematopoietic. In addition,
hematopoietic stem cells reside in the medulla of the bone and have unique ability
form different types of blood cells.21
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1.3.2 Bone Histology
The constituents of the bone are bone matrix and bone cells. The major
content of the bone matrix is inorganic material and the rest is organic material.
The composition of the bone matrix gives the characteristics of bone. The primary
constituents of organic material are collagen and proteoglycans while the primary
constituent of inorganic material is hydroxyapatite, [Ca10(PO4)6(OH)2].22 The
major functional characteristics of bone are due to collagen and mineral
components. The bone matrix is similar to the structure of concrete; collagen
fibers give flexible strength to the matrix while weight bearing strength is given
by mineral components. 23
Bone cells can be categorized into three different types: osteoblasts,
osteocytes, and osteoclasts. Each type of cells has different functions and they
originate from different places. Osteoblasts are bone forming cells which becomes
an osteocyte when it is surrounded by bone matrix. The bodies or osteocyte
occupies spaces called lacunae and the space osteocyte cell processes are called
canaliculi. Osteoclast reabsorbs or breakdowns bone and they also release
enzymes that digest protein components of the matrix. Osteochondral progenitor
cells become osteoblasts which will become osteocytes. However, osteoclasts are
derived from stem cells in red bone marrow. The formation of bone, called
ossification or osteogenesis, occurs by appositional growth.20
Bone tissue can be categorized into two different types according to the
organization of collagen fibers within the bone matrix. While randomly oriented
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collagen fibers in many directions it is called woven bone, lamellar bone is when
mature bone is organized into thin sheets or layers of lamellae.20
According to the amount of bone matrix relative to the amount of space
within the bone, both bone tissue types can be differentiated into two different
bone types, spongy and compact, as shown in Figure 2. There are more spaces in
spongy bone because it is porous because it lacks bone matrix. The
interconnecting rods or plates of bone are called trabeculae. The space is filled
with bone marrow. However, compact bone has more bone matrix so less space.20

Figure 2. Types of bone
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1.3.3 Bone Repair
Bone is a living tissue that can undergo repair if it is damaged and the repair
process consists of four major steps as shown in Figure 3.20
1. Hematoma formation: Bone fracture leads to damages to blood vessels in
the bone and surrounding periosteum. Therefore, a hematoma forms which
is a localised mass of blood released from blood vessels but confined
within an organ or a space. Usually, blood forms clot in hematoma and
consisting of fibrous proteins that stop the bleeding.
2. Callus formation: A callus is a mass of tissue that forms at a fracture site
and connects the broken ends of the bone. An internal callus forms
between the ends of the broken bones, as well as in the marrow cavity if
the fracture occurs in the diaphysis of a long bone.
3. Callus ossification: Woven spongy bone replaces the internal and external
calluses
4. Bone remodelling: Compact bone replaces woven bone, and part of the
internal callus is removed, restoring the medullary cavity.
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Figure 3. Bone Repair
1.3.4 Hydroxyapatite [Ca10(PO4)6(OH)2]
Hydroxyapatite is the primary inorganic crystalline constituent of the bone,
enamel, dentine and cement. It is also bioactive so it supports the growth of bone
by integrating in the newly formed bone tissue without dissolving or breaking
down. Carbonate, fluoride, and chloride may replace the hydroxide group which
results in thermally less stable apatites. In addition, the substituted apatite has
lower mechanical strength. The expected applications of hydroxyapatite as
biocompatible phase reinforcement in biomedical composites are:
a. Coating on metal implantations by altering the surface properties.
b. Bone fillers; provides a scaffold and encourages the rapid filling of the
void by naturally forming bone which provides an alternative to bone
grafts and eventually reduces the healing time. 24
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Some published well known methods of producing hydroxyapatite
coatings are sol-gel processing, co-precipitation, emulsion techniques, batch
hydrothermal processes, mechanical-chemical methods and chemical vapour
deposition.25 However, these methods have critical disadvantages such as high
cost of materials needed, precise control over reaction conditions, the use of
organic solvents, and time consuming preparation processes. In addition, these
methods do not provide sufficient control over particle size, agglomeration
surface area, and shape.26 Furthermore, hydroxyapatite crystallizes out of aqueous
solution when the degree of supersaturation is low.
Enormous work has been conducted to develop calcium phosphate bone
cement for example to treat hair line fractures but the cement often requires a long
time to harden. 27 Incorporation of polymers into the cement paste has been shown
to improve this problem, resulting in cement with improved compressive strength
and reduced crystalline dimensions.28
1.3.5 Metal Organic Frameworks (MOFs)
Applications of MOFs include gas storage, gas separation, as well as
catalysts but they are almost extensively limited to transition metals. In contrast,
the analogous chemistry involving the s-block remains at its infancy.29
Metal organic frameworks are crystalline compounds consisting of metal
ions or clusters coordinated to often rigid organic molecules to form 1-, 2-, or 3dimensional structures which maybe porous. The organic molecule is often called
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a linker and may involve a mono-, di-, tri-, or tetravalent ligand. The type of
metal and linker significantly influences the structure and properties of the
resulting MOFs. For instance, the metal’s coordination ability influences the size
and shape of pores by allowing a different number of ligands to bind in different
orientations.30
The extensive work on MOFs involving phosphorus based ligands in
conjunction with transition metals has demonstrated significant array of structural
features attainable by judicious ligand and donor choice in phosphonic acid
system. The phosphate [P=O(OH)2] moiety is connected to carbon center either
leading to a phosphonate [RP=O(OH)2] or a diphosphonate {R[P=O(OH)2]} if the
carbon backbone connects to two phosphonate moieties. Phosphonic acids can be
deprotonated once or twice depending on the conditions; the second deprotonation
requiring a stronger basic agent. In contrast, phosphinic acids have only one
acidic proton.
Often water is either as coordinative or as water of crystallization in the
channels is present if the crystal structure of MOFs is prepared under
hydrothermal conditions. The water may be lost in two different ways; typically
water in the canals and cavities is lost more easily than coordinated water.
However, water lost from cavities may be removed reversibly with the framework
intact, but loss of metal coordinated water often leads to structural breakdown and
loss

of

crystallinity.31

For

instance,

aluminium

diphosphonate

Al2O3P(CH2)2PO3H2O2F2.H2O contains water in the channels but can be removed
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between 100 °C and 380 °C. In contrast, the isostructural gallium compound
Ga2(O3PCH2)2HeO2F2.H2O maintains crystallinity upon loss of water. The
significant difference in the reversible water loss properties of aluminium and
gallium demonstrate how difficult it is to predict these properties and to
eventually design a compound to be synthesized. A possible explanation for the
reversible water loss might be the larger pore size of gallium species as compared
to the aluminium compound.32 Often other molecules than water can be
introduced into the channels, hence the ability of certain MOFs for gas storage.
Furthermore, the reversible loss of water may lead to structural changes
with

retention

of

the

framework.

This

is

observed

in

vanadium

ethylenediphosphonate complexes.32 Upon water loss, the complex changes from
a square pyramid to a tetrahedral metal environment, resulting in a unique
application as absorbent and catalyst. Moreover, it has been shown that fluoride
(F-) incorporation improves the formation of crystalline lattices. F- may
introduced by use of HF solutions.
The significant difference in the properties of each framework
demonstrates how difficult it is to predict and eventually design a material with
desired properties. The most significant characteristics that most researchers focus
on is the size of pores.
In biology, the growth of new cells can be enhanced with a scaffold and
the general characteristic of scaffold is having pores and an extensive surface
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area.34 Thus, biomimetric and biocompatible MOFs with open pores are being
explored in this work to explore their possible use as scaffold for bones in growth.
1.3.6 Ethylenediphosphonate in metal organic frameworks
Transition metal based ethylenediphosphonate MOFs are extensively
studied, revealing a variety of metal binding modes and deprotonation types of
this ligand system. For instance, a double deprotonation is observed in
Sn(HO3PCH2PO3H).25

Whereas

Ti(O3P(CH2)2PO3)

Ag4(O3P(CH2)2PO3).25,33 Selected

or

quadruple

deprotonation

is

MOFs

seen

in

involving

diphosphonates and alkaline earth metals have been reported for example a
doubly

deprotonated

ligand

is

observed

in

Ba(HO3PCH2CH2PO3H).7

Alternatively, but less common single/double diphosphonate deprotonation has
been observed in selected examples include MIII(H2O)(HO3P(CH2)2PO3) where M
= Fe, Ga, Al. Alkali metal diphosphonates typically contain a singly deprotonated
ligand as seen in Na(HO3PCH2CH2PO3H2).33 The stepwise deprotonation of
ethylene diphosphonate and its pH dependence is shown in Figure 5.35
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Figure 5. Deprotonation of Ethylene Diphosphonate
While a large number of transition metal diphosphonates are known, only
few alkaline earth metal based examples have disseminated.7, 38-40
The degree of deprotonation is not always easy to identify, relying on xray data and corresponding P-O bond length. P=O bond are typically the shortest,
P-O- (1.566 Å) adopt an intermediate bond length while P-OH bonds (1.524 Å)
are the longest.4 A different technique to identify the degree of protonation is
based on

31

P MASS NMR spectroscopy. It is very difficult to locate the

deprotonation site but Clearfield et al. found out the site with

31

P MASS NMR

spectroscopy. Their assumptions were later confirmed by studies on isostructural
Pr and Gd complexes.41 As an example, in Fe(H2O(HO3P(CH2)2PO3), the
protonated, P-OH, has a P-O distance of 1.573 Å being longer than the P-O
distances of the deprotonated, P-O- form, 1.503 Å.36
In 2007, Tuikka et al. reported a series of new barium diphosphonates
based on ligand different linker lengths. and obtained single crystals by gel
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crystallisation. They observed a correlation between the length of the carbon
chain and separation between the layers. Another significant characteristic was
that the deprotonation sites were not consistent.
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Chapter 2: Synthesis of diphosphonate ligand and calcium and magnesium
based diphosphonates
2.1 Synthesis of diphosphonate ligand
Phosphonate and diphosphonate ligands are often prepared by the
Michaelis-Arbuzov reaction as shown in Figure 4 and it involves the treatment of
trialkyl phosphite and an alkyl halide to form the phosphonate. This reaction is
widely used for the synthesis of various phosphonates, phosphinates and
phosphine oxides. The reaction was discovered by Michaelis in 1898 and
improved by Aleksandr Arbuzov. 41

Figure 4. Michaelis-Arbuzov reaction
Phosphorus in the resulting compounds may be in various oxidation states
according to which bond is formed, +1, +3, and +5. Examples are shown in Table
2 below.42
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Table 2. Examples of phosphorus oxyacids
Name

Oxidation
state of P

Phosphinic acid
H3PO2

+1

Phosphorous acid
H3PO3

+3

Orthophosphoric acid
H3PO4

+5

Structure

Simple bisphosphonate esters are often synthesised using MichaelisBecker syntheses. However, as aforementioned, this project will seek a different
synthetic route to obtain high yield products and this is Michaelis-Arbuzov
reaction.
The Michaelis-Arbuzov reaction follows a SN2 mechanism involving the
reaction of the nucleophilic phosphite (1) with the electrophilic alkyl halide (2) to
afford the phosphonium intermediate (3) shown in Figure 6. Triaryl phosphites,
which are unable to perform the second step of the Michaelis-Arbuzov reaction,
have been shown to produce stable phosphonium salts. Likewise, aryl and vinyl
halides are less reactive towards phosphites. The displaced halide anion reacts via
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another SN2 reaction with the phosphonium intermediate to give the desired
phosphonate (4) aand another alkyl halide (5).30

Figure 6. Stepwise mechanism of Michelis
Michelis-Arbuzov
Arbuzov Reaction

The choice
ice of ligand, 3-oxapentane-1,5-diphosphonic
diphosphonic acid,
acid is based on
the special properties and binding modes it may have compared to previously
used ligands such as ethylene diphosphonic acid and butylenes diphosphonic acid.
acid
Hence, I expect to see different product
products that will exhibit different coordination
and aggregation characteristics. Due to the geometric
eometric shape and length of 3oxapentane-1,5-diphosphonic
diphosphonic acid wee expect the formation of materials with open
and connecting channels which may be crucial for a scaffold bone material.
Previous studies done by other students in the lab have shown that different
backbone chains have an effect on the binding mode and met
metal
al coordination.
2.2 Synthesis of calcium and magnesium diphosphonate compounds
The main focus of this study was on alkaline earth metal especially
calcium and magnesium due to their presence in most biological systems.
Variables utilized in the synthesis of the Mg and Ca based target compounds
include pH, introduction of various lewis bases, as well as different temperatures.
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The pH of some reactions was adjusted to pH 7 using sodium hydroxide because
the ligand is acidic (pH 1). The reactions were conducted in water as well as
methanol and ethanol. The temperature range applied varied from room
temperature to 150°C. Lewis bases used include 1,4-diazabicyclo[2.2.2]octane
(DABCO), tetrahydrofuran (THF) and dimethylformamide (DMF). Among many
reactions only three reactions yielded precipitate. These are all listed in detail
below. All reactions were run with hydrothermal reaction.
Hydrothermal synthesis is based on the increased solubility of reagents
and products under high pressure and high temperature conditions. The improved
solubility will facilitate crystal growth. Hydrothermal conditions applied in this
work. The reaction is conducted in a thick walled glass sealed under reduced
pressure at temperatures above the boiling point of the solvent in this case, water.
As the water evaporates the, pressure increases. The method has been
advantageous for the growth of good quality crystals. When the solvent is not
water, the process is called solvothermal.40 All product yielded reactions were
maintained the temperature of 150 °C at a pressure not exceeding 15 atm.
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Chapter 3: Results and Discussion
3.1 Results
3.1.1 Preparation of Ligand, 3-Oxapentane-1,5-bisphosphonic Acid

The ligand, 3-oxapentane-1,5-bisphosphonic acid, was prepared utilizing
well known reaction Michaelis-Arbuzov. 2-bisbromoethyl ether was added to
excess triethyl phosphite. One of the reaction product, ethyl bromide, and excess
triethyl phosphite was removed from the reaction by distillation. As a result, the
reaction was straightforward as only the two reactants are present, still, byproducts and excess reactants required removal. The ratio of the 2-bisbromoethyl
ether : triethyl phosphite reagent was used in a (1:7 ratio) to speed up the reaction
and ensure the completion of the reaction.
The critical step in the reaction to improve yield is to remove the volatile
by-products, ethyl bromide, but also the excess reagent, triethyl phosphite. This
can be achieved by distillation. In addition, the key feature of this reaction was to
keep the reaction temperature below the boiling point of 2-bisbromoethyl ether to
improve the yield. The reason was that 2-bisbromoethyl ether was the limiting
agent and has a lower boiling point than triethyl phosphite. Furthermore, once the
reaction ceased the reaction mixture was left under vacuum over night to remove
undesired relative chemicals left and produced in the reaction.
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Figure 7. The first step of synthesis
The product formation was confirmed by the 1H NMR spectroscopy and
the target ester was also confirmed by 1H NMR spectroscopy, a spectrum is
shown in Figure 7.

Figure 7, NMR of intermediate product ester, C12H28O7P2
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A further reaction step is necessary to transform the ester into the desired
acid. This can be achieved by treatment with concentrated hydrochloric acid
followed by reflux for 3 days. Excess acid was added to ensure complete the
hydrolysis of the ester. After three days, the reaction mixture was concentrated
under reduced pressure. The methanol was used to remove the ethyl chloride, byproduct. This was only possible since ethyl chloride and methanol are azeotropes.
Azeotropes are a mixture of at least two different liquids. Their mixture can either
have a higher boiling point than either of the components or they can have a lower
boiling point.40 Azeotropes occur when fraction of the liquids can't be altered by
distillation. The azeotropic mixture of compounds in this case includes ethyl
chloride and methanol. Moreover, the product was also treated with diethyl ether
to dry further.

Figure 8. Second step of synthesis

Lastly, the ligand was treated with acetonitrile for further purification and
the results are shown in Figure 9 and 10. The circled peaks disappeared after the
product was treated with acetonitrile. The peaks are due to impurities because the
peaks are not starting materials and also the yellow color was gone to yield white
product.
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Figure 9, NMR of ligand before treated with acetonitrile
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Figure 10, NMR of ligand after treated with acetonitrile
The analytical methods including melting point,

1

H-NMR, and IR

spectroscopy were done beside single X-ray crystallography.
The physical and chemical properties of the ligand were explored such as
solubility of ligand, pH, and melting points. These physical and chemical
properties were considered in designing the reactions.
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3.1.2 Synthesis of calcium diphosphonate

Product 1 was obtained hydrothermally from the reaction of ligand and
calcium chloride (anhydrous) in the ratio of 1:1 using water as solvent. The
reaction was prepared in a Carius tube and the reaction mixture was pH 1. Once
the tube was sealed under reduced pressure it was placed in 150°C oven. When it
was placed in the oven the volume of solution reduced but once it was taken out
the volume increased to its starting volume. The reaction mixture remained clear
after a week in the oven. Thus, the volume of the reaction mixture was reduced by
heating with heat mantle and left at room temperature for crystallization. It took
about a month for precipitation to occur. Attempts to characterize the product by
single X-ray crystallography failed due to poor crystal quality. Three alternative
methods, melting point, IR and 1H NMR, were carried out in order to analyze the
product. These methodologies suggest product formation, but do not allow the
prediction of the exact product composition.
Comparison of the product’s melting point with CaCl2 and ligand shown
in Table 3 indicate that the melting point is significantly higher than the free
ligand, with a decomposition temperature of 262 °C. Previous students who
worked with similar compounds have suggested that the high melting point of

25

compound provides evidence that product formation took place. 1H NMR
spectroscopic analysis in D2O shows a slight shift in chemical shift between the
ligand and the reaction product, providing some indication that the ligand is
apparent in a deprotonated form. Figure 11 shows the comparison of the ligand
and the reaction product.
Table 3. Melting point comparison for compound 1
Meting point (°C)
Ligand
CaCl2
Compound 1

119-121
775 (anhydrous)
45.5 (tetrahydrate)
175 (dihydrate)
30 (hexahydrate)
262 (decomposition)
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Figure 11. 1H NMR spectra for comparison of chemical shifts of the free ligand
and compound 1

The 1H NMR spectrum which may suggest product formation due to small
changes of the chemical shifts, as summarised in Table 4. The metal coordination
influences the protons in compound when they interact with a part of a compound
which leads to the changes in the chemical shift observed in the 1H NMR.38
Table 4. Chemical shift comparison for ligand and product 1
Chemical shift (ppm)

Ligand
2.06, 3.73

Product 1
2.04, 3.75
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3.1.3 Synthesis of magnesium diphosphonate

Product 2 was obtained hydrothermally from the reaction of ligand and
magnesium sulphate (anhydrous) in the ratio of 1:1 using water as solvent. The
reaction mixture was prepared in a Carius tube and it was placed in 150°C oven
once sealed under reduced pressure. The reaction mixture was milky but became
clear after a week in the oven. To induce crystallisation the volume of the solvent
was reduced by heating with heat mantle and left at room temperature. However,
crystal quality prevented characterization by single X-ray crystallography. Three
alternative methods, melting point, IR and 1H NMR, were carried out in order to
analyze the product. These methodologies suggest product formation, but do not
allow the prediction of the exact product composition. See Table 5.
Table 5. Melting point comparison for compound 2
Meting point (°C)
Ligand
MgSO4
Compound 2

119-121
200 (monohydrate)
150 (heptahydrate)
272 (decomposition)
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As it is shown in Table 5, the melting point of the product is not close to
neither the ligand nor the magnesium sulphate but with a melting point of 272 °C.
The temperature is quite similar to compound 1.

Figure 12. 1H NMR spectra comparison of chemical shifts for free ligand and
compound 2

The 1H NMR spectrum which may suggest product formation due to small
changes of the chemical shifts, as summarized in Table 6. The metal coordination
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influences the protons in compound when they interact with a part of a compound
which leads to the changes in the chemical shift observed in the 1H NMR.38
The 1H NMR shows similar characteristic changes observed in compound
1. The chemical shifts became slight downfield compared to the ligand. Table 6
provides chemical shifts of free ligand and compound 2 for comparisons.
Table 6. Chemical shift comparison for ligand and product 2
Chemical shift (ppm)

Ligand
2.06, 3.73

Compound 2
2.06, 3.75

3.1.4 Synthesis of calcium diphosphonate

Compound 3 was obtained hydrothermally from the reaction of the ligand
and calcium nitrate in the ratio of 1:1 with water as solvent. The reaction mixture
was prepared in a Carius tube and placed in 150°C once it was sealed under
reduced pressure. The reaction mixture was still clear after a week in the oven.
Thus, the volume of the reaction mixture was reduced by heating with heat mantle
and left at room temperature for crystallization. It took a month to observe the
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formation of precipitate. However the crystallinity of the solid did not allow it’s
characterization by single X-ray crystallography.
As shown in Table 7, the melting point of the product does not compare to
ligand or the calcium nitrate starting material. The product actually decomposed
at 270 °C.
1

H NMR spectroscopy in D2O indicated a slight change in chemical shift

for the reaction product, similar to those observed for compounds 1 and 2
Table 7. Melting point comparison for compound 3
Meting point (°C)
Ligand

119-121

Ca(NO3)2

42.7 (tetrahydrate)

Compound 3

270 (decomposition)

Table 8 provides chemical shifts of free ligand and compound 3 for a
comparison.
Table 8. Chemical shift comparison for ligand and product 3
Chemical shift (ppm)

Ligand
2.06, 3.73

Compound 3
1.99, 3.73
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Figure 13. 1H NMR spectra comparisons of chemical shifts of the free ligand and
compound 3

In summary, the data obtained from analysis provide the motivation for
further studies, specifically with the aim to produce high quality crystals that can
be analyzed with single X-ray crystallography. Table 9 provides the analytical
values obtained from characterizations- clearly slight changes in chemical shifts
are observed and distinct peaks in finger print region in IR spectrum are observed
for each compound.
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Table 9. Values for 1H NMR and IR spectroscopy
Ligand

Compound 1

Compound 2

Compound 3

2.06, 3.73

2.04, 3.75

2.06, 3.75

1.99, 3.73

N/A

-0.02, +0.02

0, +0.02

-0.07, 0

IR

2920(w),

2920(s),

2919(w),

2920(s),

spectroscopy

2723(s),

2853(s),

2723(s),

2850(s),

peaks

1468(s),

1458(s),

1465(s),

1458(s),

1389(s),

1376(s),

1374(s),

1376(s),

1303(s),

1154(s),

1154(s),

1154(s),

1154 (s)

1053(s),

1065(s),

1042(s),

1037(s),

928(s),

933(s),

912(s),

933(s),

846(s),

846(s),

845(s),

722(s)

722(s),

722(s)

722(s);

Chemical
shifts (ppm)
Chemical shift
change (ppm)
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3.2 Discussion
Transition metal phosphonates are well represented in the literature. In
contrast, significantly less is known about the very challenging s-block metal.
A range of significant differences between the two groups of metals is
apparent, including the larger size of the s-block metals. The large size of the sblock metals results in large coordination numbers and a pronounced tendency
towards aggregation. The absence of energetically available d-orbital for the sblock metals, along with the electropositive characters for the s-block metals
result in mainly electrostatic bonds and s-orbital control.
The primary goal of this project was to develop synthetic routes to design
and synthesize magnesium and calcium phosphonates to develop methodologies
to obtain high quality crystals of the products. During the project a number of
synthetic methods and reaction conditions were employed. Furthermore, attempts
were made to improve the crystallinity of the reaction products. Technique
employed included the addition of co-ligands (lewis bases) but no improvement
was noticed.
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Chapter 4: Experimental
4.1 General Methods:
Reactions: All reactions were performed in hydrothermal condition except for the
synthesis of the ligand. A wide range of temperature of the oven was used
beginning from low temperature to high temperature. Reaction solvents were
selected according to the solubility of the ligand.
Analysis: 1H-NMR spectra were recorded on Bruker Avance 300 spectrometer at
300 MHz using D2O and CDCl3. The chemical shifts are given in parts per
million (ppm). Coupling constants are reported in Hertz (Hz). The solvent peak
was used as a reference value, for 1H-NMR: CDCl3 = 7.27 D2O = 4.8. Data are
reported as follows: (s = single; d = doublet; t = triplet; q = quartet; p = pentet; dd
=doublet; dt = doublet of triplets; td = triplet of doublets; bs = broad singlet). IR
spectra were obtained with a Thermo Nicolet IR – 100 spectrometer on KBr
plates. The melting point was taken with EZ melt – SRS (Stanford Research
Systems).
4.2 Synthesis of Ligand, 3-Oxapentane-1,5-bisphosphonic Acid
Bis(2-bromoethyl)ether (13.12 g, 8.67 mL, 0.069 mol) and 85.74 mL (0.5
mol) of triethyl phosphite were added to a 250 mL three-neck round-bottom flask.
The reaction mixture was then refluxed for 3 hours at approximately 80 °C
followed by vacuum distillation at 80 °C until all excess triethyl phosphite was
removed. 1H-NMR spectroscopy was used to check the completion of the
reaction. The ester was treated with 50 mL of concentrated HCl and refluxed for 3
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days at approximately 80 °C.. The crude bisphosphonic acid was treated with
MeOH (5 x 10 mL) and concentrated under reduced pressure, treated with Et2O
(20 mL) and finally concentrated under reduced pressure to yield a clear yellow
oil. The crude diphosphonic acid was allowed to dry in room temperature and
pressure for a week to obtain product
product.. Solidified diphosphonic acid was washed
with acetonitrile tto yield white crystalline solid (13.7 g, 85%, mp 119-121
119
°C;):
max(KBr)/

cm-1 2920(w), 2723(s), 1468(s), 1389(s), 1303(s), 1154
154 (P=O), 1037(s),

933(s), 722(s) ; pH 1; δH (D2O) 2.05 (4 H, dt, 3J HH 6.9, 3J HP 18),
), 3.72 (4 H, dt, 3J
HH

6.9, 3J HP 15.3)

4.3 Synthesis of calcium diphosphonate
Calcium chloride anhydrous (0.555 g, 5 mmol) and ligand 3-oxapentane1,5-bisphosphonic
bisphosphonic acid (1.2 g, 5 mmol) were dissolved in H2O (4
4 mL)
mL in a Carius
tube. The Carius
arius tube was sealed under reduced pressure and placed
place in 150 °C
oven. The clear solution was taken out of the oven after a week and the volume
was reduced and left in room temperature for crystallisation.
stallisation. The solution slowly
evaporated to yield a colorless solid after one month; mp 262 °C (decomposition);
max(KBr)/

cm-1 2920(s),
(s), 2853(s), 1458(s), 1376(s), 1154(s), 1053(s),
1
928(s),

846(s), 722(s), pH 11; δH (D2O) 2.04, 3.75
4.4 Ligand and magnesium sul
sulfate in water
Magnesium sul
sulfate anhydrous (0.6 g, 5 mmol) and ligand 3-oxapentane1,5-bisphosphonic
bisphosphonic acid (1.2 g, 5 mmol) were dissolved in H2O (4
4 mL)
mL in a Carius
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tube. The Carius
arius tube was sealed under reduced pressure and placed
place in 150 °C
oven. The clear solution was taken out of the oven after a week and the volume
wass reduced and left at room temperature for crystallisation. The solution slowly
evaporated to yiel
yield clear salts after a month in room temperature and pressure;
pressure mp
272 °C (decomposition
(decomposition);

max(KBr)/

cm-1 2919(w), 2723(s), 1465(s), 1374(s),

1154(s), 1065(s), 933(s), 846(s), 722(s); pH 1; δH (D2O) 2.06, 3.75
4.5 Synthesis of calcium diphosphonate
Calcium nitrate tetrahydrate (0.236 g, 1 mmol) and ligand 3-oxapentane1,5-bisphosphonic
bisphosphonic acid (0.24 g, 1 mmol) were dissolved in H2O (4 mL) in a
Carius tube. 1,4-Dioxane
Dioxane (0.176 g, 1 mmol) was added to the reaction mixture.
The tube was sealed under reduced pressure and placed in 150 °C for a week. The
clear solution was taken out of the oven and the vvolume
lume was reduced and left in
room temperature and for crystallization. The precipitate began to form after 3
weeks later;; mp 270 °C (decomposition);

max(KBr)/

cm-1 2920(s), 2850(s),

1458(s), 1376(s), 1154(s), 1042(s), 912(s), 845(s), 722(s); pH 1;
1 δH (D2O) 1.99,
3.73
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Chapter 5: Conclusions and Recommendations
In summary, the project entailed the ligand synthesis and once the ligand
was obtained the ligand was treated with various magnesium and calcium salts. In
three instances calcium chloride in water, magnesium sulphate in water, and
calcium nitrate in water in addition to 1,4-dioxane a solid reaction product was
obtained. Three products were obtained via hydrothermal synthesis and were
analysed using melting point, IR and 1H-NMR. Unfortunately, the detailed
analysis could not be obtained because desired single crystals were not obtained.
Three characterizations have shown a possibility of product formation in
each reaction. These include slight shifts in the 1H NMR spectra as compared to
the starting materials, indicating that some chemical changes must have occurred
during the hydrothermal reaction. In addition, the melting point of each product
was different from the starting materials. They actually decomposed which
provides a strong evidence of product formation.
Future work will include the further exploration of reaction conditions and
crystallization methods, including the addition of lewis bases, as well as other
magnesium and calcium salts. There are many more changes that can be made in
order to obtain high quality crystals.
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SUMMARY

The skeletal system plays a significant role allowing for movement and
other essential functions. There are many causes such as diseases resulting in
deformity and malfunctions. However bone has the ability to regenerate allowing
it to heal over a period of time when it is damaged. The repairing process occurs
in multiple steps. Thus, the main focus of this project was to seek a way to
enhance the healing process by introducing a biocompatible scaffold. The use of
scaffolds is common in biology to enhance the growth of new cells so the same
concept was applied to bones in repair process. Scaffolds are based on
biocompatible

magnesium

and

calcium

alkaline

earth

metals

based

diphosphonates. Magnesium and calcium are often found in most of our body
system.
The ligand system used is derived from the use of diphosphonate based
drugs in bone therapy. There are various kinds of diphosphonate based drugs
available in the market and they are used to reduce pain, reduce bone fracture and
prevent the progress of tumor growth in bone related disorders such as
osteoporosis, Paget’s disease, bone metastases, and hypercalcemia. While
exogenous phosphonic acids are known to bind to calcium in the bone,
diphosphonates are also known as agents for suppressing resorption of bone.
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Preferably the targeted scaffolds contain pores to allow the incorporation
of fluids and substances. Similar characteristics are found in metal organic
frameworks (MOFs) which provide a model system for the targeted material.
MOFs are crystalline compounds consisting of metal ions or clusters
coordinated to often rigid organic molecules to form 1-, 2-, 3-dimensional
structures which maybe porous. MOFs are usually robust, rigid and thermally
stable. They have formed used in a wide range of applications. A significant
drawback is the difficulty to control and to predict the characteristics of each
MOF. However, the focus is to produce MOFs that are 3-dimensional containing
pores.
The ligand, 3-oxapentane-1,5-diphosphonic acid, choice is based on the
special properties and binding modes it may have compared to previously used
ligands such as ethylene diphosphonic acid and butylenes diphosphonic acid.
Hence, I expect to see different products that will exhibit different coordination
and aggregation characteristics. Nevertheless, the most significant characteristic
many researchers focus is on the size of pores.
Transition metal phosphonates and diphosphonates have been widely
disseminated; however analogous s-block metal complexes are rare. A multitude
of factors contribute towards this. A range of significant differences between the
two groups of metals is apparent, including the larger size of the s-block metals.
The large size of the s-block metals results in large coordination numbers and a
pronounced tendency towards aggregation. The absence of energetically available
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d-orbital for the s-block metals, along with the electropositive characters for the sblock metals result in mainly electrostatic bonds and s-orbital control.
This project employed the well-known Michaelis-Arbuzov reaction to
prepare the target ligand. A new synthetic route for the synthesis of
diphosphonate ligand was established. The ligand was treated with different
calcium and magnesium salts using different pH, temperature, solvent and
pressure conditions affording solid products for three different reactions
conducted. In order to obtain crystals with high quality hydrothermal reaction was
employed in this project. Hydrothermal synthesis is based on the increased
solubility of reagents and products under high pressure and high temperature
conditions. The improved solubility will facilitate crystal growth. Unfortunately,
the crystal quality did not allow their characterization with single crystal X-ray
crystallography.
Three compounds were characterized with three alternative methods,
melting point, IR spectroscopy, and 1H-NMR. 1H-NMR indicated slight changes
in chemical shifts and this is quite important because the metal coordination
influences the protons in compound when they interact with a part of a compound
which leads to the changes in the chemical shift observed in the 1H NMR. In
addition, IR spectroscopy have shown changes in finger print area and this is also
important because each compounds have their own distinct peaks in this area just
like how we have our own distinct finger prints. Lastly, melting point tests have
given a strong indication of the product formation. All three compounds had
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different melting points and slight shifts in 1H NMR spectra as compared to the
starting materials, indicating that some chemical changes must have occurred
during the hydrothermal reaction.
In summary, a new synthetic route to synthesize the ligand is established
and three products have been formed although the quality prevented from
producing details of crystallographic data and structure refinement parameters.
However, the results of this project have shown the need of further
studies with corresponding chemistry. Future work will include the further
exploration of reaction conditions and crystallization methods, including the
addition of lewis bases, as well as other magnesium and calcium salts.

